Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma.
You R, Zou X, Ding X, Zhang WJ, Zhang MX, Wang X, Xu HS, Liu YL, Ouyang YF, Duan CY, Gu CM, Wang ZQ, Liu YP, Hua YJ, Huang PY, Chen MY.
You R, et al. Among authors: wang x, wang zq.
Med. 2022 Oct 14;3(10):664-681.e6. doi: 10.1016/j.medj.2022.07.009. Epub 2022 Aug 29.
Med. 2022.
PMID: 36041429
Free article.